YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulationMarzia Pennati, Nadia Zaffaroni, Alessia Lopergolo et al.|International Journal of Cancer|2014Cited by 30
Evaluation of Mediators Associated with the Inflammatory Response in Prostate Cancer Patients Undergoing RadiotherapyN. Bedini, R. Valdagni, A. Cicchetti et al.|Disease Markers|2018Cited by 23